- Home
- Publications
- Publication Search
- Publication Details
Title
Curaxin CBL0137 Exerts Anticancer Activity via Diverse Mechanisms
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-12-07
DOI
10.3389/fonc.2018.00598
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The FACT inhibitor CBL0137 Synergizes with Cisplatin in Small-Cell Lung Cancer by IncreasingNOTCH1Expression and Targeting Tumor-Initiating Cells
- (2018) Sarmishtha De et al. CANCER RESEARCH
- Role of Chromatin Damage and Chromatin Trapping of FACT in Mediating the Anticancer Cytotoxicity of DNA-Binding Small-Molecule Drugs
- (2018) Elimelech Nesher et al. CANCER RESEARCH
- FACT Sets a Barrier for Cell Fate Reprogramming in Caenorhabditis elegans and Human Cells
- (2018) Ena Kolundzic et al. DEVELOPMENTAL CELL
- Mutant p53 as a target for cancer treatment
- (2017) Michael J. Duffy et al. EUROPEAN JOURNAL OF CANCER
- FACT is a sensor of DNA torsional stress in eukaryotic cells
- (2017) Alfiya Safina et al. NUCLEIC ACIDS RESEARCH
- The bad seed gardener: Deubiquitinases in the cancer stem-cell signaling network and therapeutic resistance
- (2017) Guan-Zhong Qiu et al. PHARMACOLOGY & THERAPEUTICS
- Level of FACT defines the transcriptional landscape and aggressive phenotype of breast cancer cells
- (2017) Daria Fleyshman et al. Oncotarget
- Critical Role for GAB2 in Neuroblastoma Pathogenesis through the Promotion of SHP2/MYCN Cooperation
- (2017) Xiaoling Zhang et al. Cell Reports
- A Designed Inhibitor of p53 Aggregation Rescues p53 Tumor Suppression in Ovarian Carcinomas
- (2016) Alice Soragni et al. CANCER CELL
- Preclinical Validation of a Single-Treatment Infusion Modality That Can Eradicate Extremity Melanomas
- (2016) Minhyung Kim et al. CANCER RESEARCH
- Pharmacological Targeting of the Histone Chaperone Complex FACT Preferentially Eliminates Glioblastoma Stem Cells and Prolongs Survival in Preclinical Models
- (2016) Josephine Kam Tai Dermawan et al. CANCER RESEARCH
- Inhibiting the pro-tumor and transcription factor FACT: Mechanisms
- (2016) N. V. Maluchenko et al. MOLECULAR BIOLOGY
- SSRP1 Contributes to the Malignancy of Hepatocellular Carcinoma and Is Negatively Regulated by miR-497
- (2016) Qianshan Ding et al. MOLECULAR THERAPY
- Anticancer drug candidate CBL0137, which inhibits histone chaperone FACT, is efficacious in preclinical orthotopic models of temozolomide-responsive and -resistant glioblastoma
- (2016) Tara A. Barone et al. NEURO-ONCOLOGY
- Targeted Therapy and Checkpoint Immunotherapy Combinations for the Treatment of Cancer
- (2016) Paul E. Hughes et al. TRENDS IN IMMUNOLOGY
- COTI-2, a novel small molecule that is active against multiple human cancer cell lines in vitro and in vivo
- (2016) Kowthar Y. Salim et al. Oncotarget
- Structure and function of histone chaperone FACT
- (2015) M. T. Bondarenko et al. MOLECULAR BIOLOGY
- Therapeutic targeting of the MYC signal by inhibition of histone chaperone FACT in neuroblastoma
- (2015) Daniel R. Carter et al. Science Translational Medicine
- EGFR and NF-κB: partners in cancer
- (2015) Kateryna Shostak et al. TRENDS IN MOLECULAR MEDICINE
- Quinacrine promotes autophagic cell death and chemosensitivity in ovarian cancer and attenuates tumor growth
- (2015) Ashwani Khurana et al. Oncotarget
- Expression of FACT in mammalian tissues suggests its role in maintaining of undifferentiated state of cells
- (2015) Henry Garcia et al. Oncotarget
- Curaxin CBL0137 eradicates drug resistant cancer stem cells and potentiates efficacy of gemcitabine in preclinical models of pancreatic cancer
- (2015) Catherine Burkhart et al. Oncotarget
- The paradigm of mutant p53-expressing cancer stem cells and drug resistance
- (2014) Yoav Shetzer et al. CARCINOGENESIS
- Cancer stem cells - important players in tumor therapy resistance
- (2014) Selcuk Colak et al. FEBS Journal
- Quinacrine Overcomes Resistance to Erlotinib by Inhibiting FACT, NF- B, and Cell-Cycle Progression in Non-Small Cell Lung Cancer
- (2014) J. K. T. Dermawan et al. MOLECULAR CANCER THERAPEUTICS
- Small molecule induced reactivation of mutant p53 in cancer cells
- (2013) Xiangrui Liu et al. NUCLEIC ACIDS RESEARCH
- Targeting Notch signaling pathway in cancer: Clinical development advances and challenges
- (2013) Naoko Takebe et al. PHARMACOLOGY & THERAPEUTICS
- Facilitates Chromatin Transcription Complex Is an “Accelerator” of Tumor Transformation and Potential Marker and Target of Aggressive Cancers
- (2013) Henry Garcia et al. Cell Reports
- Allele-Specific p53 Mutant Reactivation
- (2012) Xin Yu et al. CANCER CELL
- Targeting FACT Complex Suppresses Mammary Tumorigenesis in Her2/neu Transgenic Mice
- (2012) I. E. Koman et al. Cancer Prevention Research
- EGFR-Induced and PKCε Monoubiquitylation-Dependent NF-κB Activation Upregulates PKM2 Expression and Promotes Tumorigenesis
- (2012) Weiwei Yang et al. MOLECULAR CELL
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Curaxins: A New Family of Non-genotoxic Multitargeted Anticancer Agents
- (2011) Valeria Di Bussolo et al. ChemMedChem
- Quinacrine has anticancer activity in breast cancer cells through inhibition of topoisomerase activity
- (2011) Ranjan Preet et al. INTERNATIONAL JOURNAL OF CANCER
- Cancer Drug Discovery Faces the FACT
- (2011) G. F. Draetta et al. Science Translational Medicine
- Curaxins: Anticancer Compounds That Simultaneously Suppress NF- B and Activate p53 by Targeting FACT
- (2011) A. V. Gasparian et al. Science Translational Medicine
- Comprehensive genomic characterization defines human glioblastoma genes and core pathways
- (2008) Roger McLendon et al. NATURE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now